Portfolio

deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024

April 29, 2024

deepull, a medical diagnostics company developing culture-free diagnostic solutions for rapid pathogen identification in sepsis and other acute infections, today announces the launch of its UllCORE diagnostic system, currently in development, with its first application in the early detection of sepsis.

 

Read more